Breastfeeding did not appear to be associated with a higher risk of developing locoregional recurrences or contralateral breast cancers,” researchers wrote.

The test, developed in part by Johns Hopkins researchers, will dramatically increase access to early detection and treatment ...

The current quarter introduced the 15% onetime stock dividend and confirmed accelerated site activation for OVATION 3, compared to the previous quarter's focus on initial site readiness and ...

The findings not only demonstrate the number of legal barriers faced by various sociodemographic groups but also highlight vulnerable populations with greater need of legal navigation, informing ...

New research has revealed factors associated with an increased risk of COVID-19-related death and hospitalization among patients with cancer.

Imunon, Inc. ( NASDAQ: IMNN) Q2 2025 Earnings Conference Call August 5, 2025 11:00 AM ET Douglas V. Faller - Chief Medical Officer Khursheed Anwer - Executive VP & Chief Scientific Officer Kimberly ...

Bain Capital will make a $300 million funding in the new company, while BMY will out-license five immunology candidates.

Mysuru's expanding medical infrastructure includes new public healthcare facilities, such as the Nephro-Urology Institute and Endocrinology Centre.

Average selling prices of Illuccix will likely decrease when its transitional pass-through payment status expires in 2025.

President Donald Trump’s administration on Tuesday proposed revoking a scientific finding that has long been the central ...

Given Yakult’s record in attaining 2%-4% penetration in many emerging markets, upside potential in the areas outside three first-tier cities—currently representing 80% of Yakult’s target population in ...

"Alzheimer's disease impacts too many people, more than breast cancer ... Research Center, also funded by the NIH. There has ...